These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28460024)

  • 41. Portuguese Observational Study of Ischaemic Stroke in Patients Medicated with Non-Vitamin K Antagonist Oral Anticoagulants.
    Beato-Coelho J; Marto JP; Alves JN; Marques-Matos C; Calado S; Araújo J; Cunha L; Pinho J; Azevedo E; Viana-Baptista M; Sargento-Freitas J
    Eur Neurol; 2018; 79(1-2):108-112. PubMed ID: 29421803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
    Forslund T; Wettermark B; Andersen M; Hjemdahl P
    Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Stroke prevention in atrial fibrillation in Germany. Situational analysis of treatment reality based on retrospective data].
    Mergenthaler U; Kostev K; Moosmang S; Thate-Waschke IM; Haas S
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):26-32. PubMed ID: 29204949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation].
    Helms TM; Silber S; Schäfer A; Masuhr F; Palm F; Darius H; Schrör K; Bänsch D; Bramlage P; Hankowitz J; Karle CA; Stargardt T; Weil J; Geller JC
    Herzschrittmacherther Elektrophysiol; 2016 Sep; 27(3):295-306. PubMed ID: 27576696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation.
    Dakay K; Chang AD; Hemendinger M; Cutting S; McTaggart RA; Jayaraman MV; Chu A; Panda N; Song C; Merkler A; Gialdini G; Kummer B; Lerario MP; Kamel H; Elkind MSV; Furie KL; Yaghi S
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):192-197. PubMed ID: 28918087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Proportion of Preventable Thrombectomy Procedures with Improved Atrial Fibrillation Stroke Prevention.
    Sur NB; Saini V; Torres LF; Atchaneeyasakul K; Malik AM; Yavagal DR; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105599. PubMed ID: 33545519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anticoagulation with atrial fibrillation].
    Zellerhoff S; Goette A; Kirchhof P
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):89-94. PubMed ID: 16786467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age threshold for the use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation: insights into the optimal assessment of age and incident comorbidities.
    Chao TF; Lip GYH; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Chen SA
    Eur Heart J; 2019 May; 40(19):1504-1514. PubMed ID: 30605505
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.
    Palamaner Subash Shantha G; Bhave PD; Girotra S; Hodgson-Zingman D; Mazur A; Giudici M; Chrischilles E; Vaughan Sarrazin MS
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28408716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of non-vitamin-K oral anticoagulants on stroke severity compared to warfarin: a meta-analysis of randomized controlled trials.
    Costello M; Murphy R; Judge C; Ruttledge S; Gorey S; Loughlin E; Hughes D; Nolan A; O'Donnell MJ; Canavan M
    Eur J Neurol; 2020 Mar; 27(3):413-418. PubMed ID: 31774244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
    Masbah N; Macleod MJ
    Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenosine diphosphate-induced platelet aggregation might contribute to poor outcomes in atrial fibrillation-related ischemic stroke.
    Choi JH; Cha JK; Huh JT
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e215-20. PubMed ID: 24274935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the CHA
    Yao X; Gersh BJ; Sangaralingham LR; Kent DM; Shah ND; Abraham NS; Noseworthy PA
    Am J Cardiol; 2017 Nov; 120(9):1549-1556. PubMed ID: 28844514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relationship between the pre-admission CHA2DS2-VASc score and proximal artery occlusion in patients with acute stroke and atrial fibrillation.
    Sakamoto Y; Sato S; Hama Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2015 Jul; 22(7):1081-7. PubMed ID: 25856091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Carmo J; Ferreira J; Costa F; Carmo P; Cavaco D; Carvalho S; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Oct; 244():196-201. PubMed ID: 28679480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.